Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2016 No.24

Total 23 articles

An analysis on designation and marketing authorizations of orphan medicinal products from 2000 to 2015 in EULI Xuan, DU Xiao-chun, ZONG Xin

2761-2765

Some important considerations on the evaluation of male reproductive toxicity for pharmaceuticals and introduction of FDA's related guidancesZHANG Li-jiang, HUANG Fang-hua, WANG Qing-li, ZHENG Gao-li

2766-2772

Evaluation of the toxicity of vinorelbine bitartrate injectable emulsion and VRL aqueous injection in zebrafish张洪瑶, 贾飞, 钱璟, 劳乔聪, 刘洪翠, 李春启, 陶巧凤, 郭殿武

2773-2779

International pharmacoeconomics review of erlotinib in the treatment of non-small cell lung cancerZHANG Dong, LI Xuan, LIU Yue-hua, ZHU Liu-bao

2780-2786

Collection and analysis of the data of plants containing emodin-8-O-β-D-glucopyranoside in ChinaLI Kai-ming, SUN Zhen-xiao

2787-2792

Ethics and rights protection of vulnerable group in clinical trials of drugs for dementia曾令烽, 刘军, 潘建科, 曹烨, 包文虎, 关梓桐, 朱黎婷, 曹倩, 李晓彦

2793-2798

Preliminary discussion on safety evaluation of traditional Chinese medicine in early clinical researchLI Rui, CAO Wei-yi, TANG Xu-dong, SUN Ming-yue, LU Fang, GAO Rui

2799-2803

Risk of clinical trials of innovative drugs and the protection of subjectsZHONG Jiao, WANG Li-ping

2804-2806

Comparison of the expedited programs of patent drugs in China and America based on the empirical analysis of conditional approval systems for innovative drugsDING Jin-xi, LI Peng-hui, YAO Xue-fang

2807-2813

Feasibility study on the implementation of patent linkage system in China——Based on analysis of stakeholdersYAO Xue-fang, ZHANG Guo-cheng, DING Jin-xi

2814-2820